Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Safety and effectiveness of direct oral anticoagulants versus vitamin K antagonists: results from 3 Italian regions.

Kirchmayer U, Narduzzi S, Mayer F, Tuccori M, Leoni O, Belleudi V, Di Martino M, Lallo A, Addis A, Davoli M.

Recenti Prog Med. 2019 Apr;110(4):195-202. doi: 10.1701/3154.31345.

PMID:
31066365
2.

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies.

Ferraro S, Leonardi L, Convertino I, Blandizzi C, Tuccori M.

Front Pharmacol. 2019 Mar 19;10:247. doi: 10.3389/fphar.2019.00247. eCollection 2019.

3.

Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.

Raschi E, Mazzarella A, Antonazzo IC, Bendinelli N, Forcesi E, Tuccori M, Moretti U, Poluzzi E, De Ponti F.

Target Oncol. 2019 Apr;14(2):205-221. doi: 10.1007/s11523-019-00632-w.

PMID:
30927173
4.

Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives.

Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte JR, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R.

Drug Saf. 2019 May;42(5):683-687. doi: 10.1007/s40264-018-0768-6. No abstract available.

PMID:
30565019
5.

The usefulness of listening social media for pharmacovigilance purposes: a systematic review.

Convertino I, Ferraro S, Blandizzi C, Tuccori M.

Expert Opin Drug Saf. 2018 Nov;17(11):1081-1093. doi: 10.1080/14740338.2018.1531847. Epub 2018 Oct 12. Review.

PMID:
30285501
6.

Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis.

Convertino I, Salvadori S, Pecori A, Galiulo MT, Ferraro S, Parrilli M, Corona T, Turchetti G, Blandizzi C, Tuccori M.

Drug Saf. 2019 Mar;42(3):427-444. doi: 10.1007/s40264-018-0737-0.

PMID:
30276630
7.

Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.

Tuccori M, Convertino I, Galiulo MT, Marino A, Capogrosso-Sansone A, Blandizzi C.

Expert Opin Drug Saf. 2017 Oct;16(10):1133-1148. doi: 10.1080/14740338.2017.1361401. Epub 2017 Aug 4. Review.

PMID:
28748718
8.

Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Capogrosso Sansone A, Convertino I, Galiulo MT, Salvadori S, Pieroni S, Knezevic T, Mantarro S, Marino A, Hauben M, Blandizzi C, Tuccori M.

Drug Saf. 2017 Oct;40(10):895-909. doi: 10.1007/s40264-017-0564-8.

PMID:
28681266
9.

Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope.

Pasqualetti G, Calsolaro V, Bini G, Dell'Agnello U, Tuccori M, Marino A, Capogrosso-Sansone A, Rafanelli M, Santini M, Orsitto E, Ungar A, Blandizzi C, Monzani F.

Clin Interv Aging. 2017 Apr 13;12:687-695. doi: 10.2147/CIA.S127824. eCollection 2017.

10.
11.

Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery.

Bate A, Beckmann J, Dodoo A, Härmark L, Hartigan-Go K, Hegerius A, Lindquist M, van Puijenbroek E, Tuccori M, Hagemann U.

Drug Saf. 2017 Mar;40(3):191-199. doi: 10.1007/s40264-016-0495-9.

PMID:
28101815
12.

Hepatitis C virus infection: opportunities for an earlier detection in primary care.

Lapi F, Capogrosso Sansone A, Mantarro S, Simonetti M, Tuccori M, Blandizzi C, Rossi A, Corti G, Bartoloni A, Bellia A, Baiocchi L, Cricelli I, Cricelli C.

Eur J Gastroenterol Hepatol. 2017 Mar;29(3):271-276. doi: 10.1097/MEG.0000000000000785.

PMID:
27849644
13.

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Convertino I, Sansone AC, Marino A, Galiulo MT, Mantarro S, Antonioli L, Fornai M, Blandizzi C, Tuccori M.

Drug Saf. 2016 Oct;39(10):903-24. doi: 10.1007/s40264-016-0435-8. Review.

PMID:
27289228
14.

SSRIs and birth defects: can a new statistical approach resolve old controversies?

Tuccori M, Blandizzi C.

Evid Based Ment Health. 2016 Aug;19(3):e19. doi: 10.1136/eb-2015-102208. Epub 2016 Apr 21. No abstract available.

PMID:
27102213
15.

Pioglitazone use and risk of bladder cancer: population based cohort study.

Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L.

BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541.

16.

Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.

Montagnani S, Tuccori M, Testi A, Cristofano M, Corona T, Salvadori S, Scarpignato C, Blandizzi C.

Int J Clin Pharm. 2016 Aug;38(4):829-37. doi: 10.1007/s11096-016-0291-8. Epub 2016 Mar 22.

PMID:
27003828
17.

RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.

Tuccori M, Filion KB, Azoulay L.

J Natl Cancer Inst. 2015 Dec 27;108(2). pii: djv384. doi: 10.1093/jnci/djv384. Print 2016 Feb. No abstract available.

PMID:
26711870
18.

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.

Tuccori M, Wu JW, Yin H, Majdan A, Azoulay L.

Diabetes Care. 2015 Nov;38(11):2083-9. doi: 10.2337/dc15-1358. Epub 2015 Sep 4.

PMID:
26341130
19.

Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.

Capogrosso Sansone A, Mantarro S, Tuccori M, Ruggiero E, Montagnani S, Convertino I, Marino A, Fornai M, Antonioli L, Corona T, Garibaldi D, Blandizzi C.

Drug Saf. 2015 Oct;38(10):869-88. doi: 10.1007/s40264-015-0336-2. Review.

PMID:
26316054
20.

Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.

Martinucci I, Blandizzi C, de Bortoli N, Bellini M, Antonioli L, Tuccori M, Fornai M, Marchi S, Colucci R.

Pharmacogenomics. 2015;16(5):523-39. doi: 10.2217/pgs.15.12. Review.

PMID:
25916523
21.

Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.

Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V, Orso G, Tuccori M, Scarpignato C, Blandizzi C, Fornai M.

PLoS One. 2014 Dec 30;9(12):e116253. doi: 10.1371/journal.pone.0116253. eCollection 2014.

22.

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.

Tuccori M, Montagnani S, Capogrosso-Sansone A, Mantarro S, Antonioli L, Fornai M, Blandizzi C.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):61-75. doi: 10.1586/17512433.2015.974555. Epub 2014 Nov 3. Review.

PMID:
25363790
23.

Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.

Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, Edwards BD, Edwards IR, Hartigan-Go K, Lindquist M, McEwen J, Moride Y, Olsson S, Pal SN, Soulaymani-Bencheikh R, Tuccori M, Vaca CP, Wong IC.

Drug Saf. 2014 Oct;37(10):743-59. doi: 10.1007/s40264-014-0216-1. No abstract available.

PMID:
25171836
24.

Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Tuccori M, Montagnani S, Mantarro S, Capogrosso-Sansone A, Ruggiero E, Saporiti A, Antonioli L, Fornai M, Blandizzi C.

CNS Drugs. 2014 Mar;28(3):249-72. doi: 10.1007/s40263-013-0135-1. Review.

PMID:
24435290
25.

NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?

Fornai M, Antonioli L, Colucci R, Pellegrini C, Giustarini G, Testai L, Martelli A, Matarangasi A, Natale G, Calderone V, Tuccori M, Scarpignato C, Blandizzi C.

J Pharmacol Exp Ther. 2014 Jan;348(1):86-95. doi: 10.1124/jpet.113.207118. Epub 2013 Oct 17.

PMID:
24135073
26.

Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.

Pugi A, Bonaiuti R, Maggini V, Moschini M, Tuccori M, Leone R, Rossi M, Motola D, Piccinni C, Ferrazin F, Sottosanti L, Mugelli A, Vannacci A, Lapi F.

Am J Health Syst Pharm. 2013 Jun 15;70(12):1039-46. doi: 10.2146/ajhp120665.

PMID:
23719881
27.

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Kast RE, Boockvar JA, Brüning A, Cappello F, Chang WW, Cvek B, Dou QP, Duenas-Gonzalez A, Efferth T, Focosi D, Ghaffari SH, Karpel-Massler G, Ketola K, Khoshnevisan A, Keizman D, Magné N, Marosi C, McDonald K, Muñoz M, Paranjpe A, Pourgholami MH, Sardi I, Sella A, Srivenugopal KS, Tuccori M, Wang W, Wirtz CR, Halatsch ME.

Oncotarget. 2013 Apr;4(4):502-30. Review.

28.

The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.

Antonioli L, Colucci R, Pellegrini C, Giustarini G, Tuccori M, Blandizzi C, Fornai M.

Pharmacol Ther. 2013 Aug;139(2):157-88. doi: 10.1016/j.pharmthera.2013.04.002. Epub 2013 Apr 13. Review.

PMID:
23588157
29.

Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome.

Colucci R, Gambaccini D, Ghisu N, Rossi G, Costa F, Tuccori M, De Bortoli N, Fornai M, Antonioli L, Ricchiuti A, Mumolo MG, Marchi S, Blandizzi C, Bellini M.

PLoS One. 2013;8(2):e54831. doi: 10.1371/journal.pone.0054831. Epub 2013 Feb 5.

30.

Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient.

Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C.

BMC Geriatr. 2012 Nov 13;12:69. doi: 10.1186/1471-2318-12-69.

31.

Guillain-Barré syndrome following adalimumab treatment.

Manganelli S, Rossi M, Tuccori M, Galeazzi M.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4):592. Epub 2012 Aug 29. No abstract available.

PMID:
22931583
32.

Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases.

Tuccori M, Pisani C, Bachini L, Pardini M, Mantarro S, Antonioli L, Fornai M, Rubinelli M, Cirinei C, Blandizzi C.

Dermatology. 2012;224(3):212-4. doi: 10.1159/000337412. Epub 2012 May 11.

PMID:
22584489
33.

Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.

Colucci R, Antonioli L, Bernardini N, Ippolito C, Segnani C, Awwad O, Tuccori M, Blandizzi C, Scarpignato C, Fornai M.

J Pharmacol Exp Ther. 2012 Jul;342(1):140-9. doi: 10.1124/jpet.111.190116. Epub 2012 Apr 10.

PMID:
22495067
34.

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, Blandizzi C, Fornai M.

Curr Drug Targets. 2012 Jun;13(6):842-62. Review.

PMID:
22250650
35.

Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting.

Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, Bonaiuti R, Antonioli L, Fornai M, Giustarini G, Scollo C, Corona T, Ferrazin F, Sottosanti L, Blandizzi C.

Drug Saf. 2011 Oct 1;34(10):849-59. doi: 10.2165/11593120-000000000-00000.

PMID:
21879779
36.

ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.

Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG, Danesi R, Tuccori M, Pantaloni M, D'Aniello C.

Clin Breast Cancer. 2011 Oct;11(5):283-96. doi: 10.1016/j.clbc.2011.03.020. Epub 2011 May 11. Review.

PMID:
21729665
37.

A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric 'purinome' concept.

Antonioli L, Fornai M, Colucci R, Tuccori M, Blandizzi C.

Br J Pharmacol. 2011 Nov;164(6):1577-9. doi: 10.1111/j.1476-5381.2011.01529.x.

38.

Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?

Antonioli L, Fornai M, Colucci R, Tuccori M, Blandizzi C.

Expert Opin Investig Drugs. 2011 Jun;20(6):717-21. doi: 10.1517/13543784.2011.579104. Epub 2011 Apr 21. No abstract available.

PMID:
21506907
39.

Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district.

Cristiani C, Tuccori M, Pepe P, Sarteschi A, Maddalo F, Simonini G, Michi P, Consigli V, Fornai M, Antonioli L, Blandizzi C.

Vaccine. 2011 Apr 18;29(18):3443-8. doi: 10.1016/j.vaccine.2011.02.068. Epub 2011 Mar 9.

PMID:
21396903
40.

Autoimmune hemolytic anemia following MF59-adjuvanted influenza vaccine administration: a report of two cases.

Montagnani S, Tuccori M, Lombardo G, Testi A, Mantarro S, Ruggiero E, Blandizzi C.

Ann Pharmacother. 2011 Jan;45(1):e8. doi: 10.1345/aph.1P480. Epub 2010 Dec 28.

PMID:
21189364
41.

Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.

Tuccori M, Focosi D, Blandizzi C, Pelosini M, Montagnani S, Maggi F, Pistello M, Antonioli L, Fornai M, Pepe P, Rossi G, Petrini M.

Oncologist. 2010;15(11):1214-9. doi: 10.1634/theoncologist.2010-0098. Epub 2010 Nov 1.

42.

Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis.

Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C.

Eur J Pharmacol. 2011 Jan 15;650(2-3):639-49. doi: 10.1016/j.ejphar.2010.10.041. Epub 2010 Oct 27.

PMID:
21034735
43.

Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.

Fornai M, Colucci R, Antonioli L, Awwad O, Ugolini C, Tuccori M, Fulceri F, Natale G, Basolo F, Blandizzi C.

Pharmacol Res. 2011 Jan;63(1):59-67. doi: 10.1016/j.phrs.2010.10.013. Epub 2010 Oct 20.

PMID:
20969958
44.

Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.

Gori G, Spinelli G, Spinelli C, Tuccori M, Blandizzi C, Del Tacca M.

Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):642-6. doi: 10.1038/nrgastro.2010.152. Epub 2010 Oct 12.

PMID:
20938461
45.

Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A.

Drug Saf. 2010 Sep 1;33(9):789-99. doi: 10.2165/11536810-000000000-00000.

PMID:
20701411
46.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
47.

The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.

Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, Da Settimo F, La Motta C, Natale G, Duranti E, Virdis A, Blandizzi C.

J Pharmacol Exp Ther. 2010 Nov;335(2):434-42. doi: 10.1124/jpet.110.171223. Epub 2010 Jul 28.

PMID:
20668053
48.

Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D, Tuccori M, Conforti A.

Drug Saf. 2010 Aug 1;33(8):667-75. doi: 10.2165/11534400-000000000-00000.

PMID:
20635825
49.

Progressive multifocal leukoencephalopathy: what's new?

Focosi D, Marco T, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M.

Neuroscientist. 2010 Jun;16(3):308-23. doi: 10.1177/1073858409356594. Review.

PMID:
20479473
50.

Transient acute liver failure complicating transurethral resection syndrome.

Tuccori M, Guidi B, Montagnani S, Fornai M, Antonioli L, Blandizzi C, di Paolo M.

Scand J Urol Nephrol. 2010 Sep;44(4):269-72. doi: 10.3109/00365591003636612.

PMID:
20199344

Supplemental Content

Loading ...
Support Center